Literature DB >> 22372994

Family history of venous thromboembolism is associated with increased risk for thrombosis in multiple myeloma: a population-based study.

S Y Kristinsson, L Goldin, I Turesson, M Hultcrantz, M Björkholm, O Landgren.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22372994      PMCID： PMC7241862          DOI： 10.1111/j.1538-7836.2012.04676.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  20 in total

1.  The value of family history as a risk indicator for venous thrombosis.

Authors:  Irene D Bezemer; Felix J M van der Meer; Jeroen C J Eikenboom; Frits R Rosendaal; Carine J M Doggen
Journal:  Arch Intern Med       Date:  2009-03-23

2.  Familial risk of venous thromboembolism: a nationwide cohort study.

Authors:  H T Sørensen; A H Riis; L J Diaz; E W Andersen; J A Baron; P K Andersen
Journal:  J Thromb Haemost       Date:  2011-02       Impact factor: 5.824

3.  Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: a clinical trial coordinated by the Eastern Cooperative Oncology Group.

Authors:  S Vincent Rajkumar; Emily Blood; David Vesole; Rafael Fonseca; Philip R Greipp
Journal:  J Clin Oncol       Date:  2005-12-19       Impact factor: 44.544

4.  Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study.

Authors:  Sigurdur Y Kristinsson; Ruth M Pfeiffer; Magnus Björkholm; Lynn R Goldin; Sam Schulman; Cecilie Blimark; Ulf-Henrik Mellqvist; Anders Wahlin; Ingemar Turesson; Ola Landgren
Journal:  Blood       Date:  2010-03-18       Impact factor: 22.113

5.  Determination of age-specific and sex-specific familial risks for the different manifestations of venous thromboembolism: a nationwide family study in Sweden.

Authors:  Bengt Zöller; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  Thromb Haemost       Date:  2011-05-26       Impact factor: 5.249

6.  Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study.

Authors:  J A Heit; M D Silverstein; D N Mohr; T M Petterson; W M O'Fallon; L J Melton
Journal:  Arch Intern Med       Date:  2000-03-27

7.  Family history and inherited thrombophilia.

Authors:  G L van Sluis; M Söhne; D Y El Kheir; M W Tanck; V E A Gerdes; H R Büller
Journal:  J Thromb Haemost       Date:  2006-10       Impact factor: 5.824

8.  Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS).

Authors:  Sham Mailankody; Ruth M Pfeiffer; Sigurdur Y Kristinsson; Neha Korde; Magnus Bjorkholm; Lynn R Goldin; Ingemar Turesson; Ola Landgren
Journal:  Blood       Date:  2011-07-27       Impact factor: 22.113

9.  Family history as a risk factor for venous thromboembolism.

Authors:  Soledad Noboa; Grégoire Le Gal; Karine Lacut; Bernard Mercier; Christophe Leroyer; Emmanuel Nowak; Dominique Mottier; Emmanuel Oger
Journal:  Thromb Res       Date:  2008-02-20       Impact factor: 3.944

10.  Initial genome sequencing and analysis of multiple myeloma.

Authors:  Michael A Chapman; Michael S Lawrence; Jonathan J Keats; Kristian Cibulskis; Carrie Sougnez; Anna C Schinzel; Christina L Harview; Jean-Philippe Brunet; Gregory J Ahmann; Mazhar Adli; Kenneth C Anderson; Kristin G Ardlie; Daniel Auclair; Angela Baker; P Leif Bergsagel; Bradley E Bernstein; Yotam Drier; Rafael Fonseca; Stacey B Gabriel; Craig C Hofmeister; Sundar Jagannath; Andrzej J Jakubowiak; Amrita Krishnan; Joan Levy; Ted Liefeld; Sagar Lonial; Scott Mahan; Bunmi Mfuko; Stefano Monti; Louise M Perkins; Robb Onofrio; Trevor J Pugh; S Vincent Rajkumar; Alex H Ramos; David S Siegel; Andrey Sivachenko; A Keith Stewart; Suzanne Trudel; Ravi Vij; Douglas Voet; Wendy Winckler; Todd Zimmerman; John Carpten; Jeff Trent; William C Hahn; Levi A Garraway; Matthew Meyerson; Eric S Lander; Gad Getz; Todd R Golub
Journal:  Nature       Date:  2011-03-24       Impact factor: 49.962
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.